APA (7th ed.) Citation

JM, H., RY, R., Y, B., JC, G., W, X., XZ, J., . . . FJ, G. (2018). Ulinastatin Inhibits Osteoclastogenesis and Suppresses Ovariectomy-Induced Bone Loss by Downregulating uPAR. Frontiers in pharmacology, 9, 1016. https://doi.org/10.3389/fphar.2018.01016

Chicago Style (17th ed.) Citation

JM, Huang, et al. "Ulinastatin Inhibits Osteoclastogenesis and Suppresses Ovariectomy-Induced Bone Loss by Downregulating UPAR." Frontiers in Pharmacology 9 (2018): 1016. https://doi.org/10.3389/fphar.2018.01016.

MLA (9th ed.) Citation

JM, Huang, et al. "Ulinastatin Inhibits Osteoclastogenesis and Suppresses Ovariectomy-Induced Bone Loss by Downregulating UPAR." Frontiers in Pharmacology, vol. 9, 2018, p. 1016, https://doi.org/10.3389/fphar.2018.01016.